Coverage dated October 9, 2025 to October 10, 2025

President Trump announces new drug-price deal with AstraZeneca

Headline from Foxla

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration. Here’s what we know.

Foxla's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

24 articles, oldest first.

The Hill
Trump announces drug pricing deal with AstraZeneca (opens The Hill)
Published Oct 9, 2025
The Hill's feed description
President Trump announces AstraZeneca's commitment to charge less for prescription drugs to Americans, aligning with his MFN policy.
Washington Examiner
Trump to announce deal with AstraZeneca to lower drug costs (opens Washington Examiner)
Published Oct 9, 2025
Washington Examiner's feed description
AstraZeneca will mark the second company to sign on to Trump's "most favored nation" drug pricing plan to lower prices in the U.S.
Seattle Times
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal (opens Seattle Times)
Published Oct 9, 2025
Seattle Times's feed description
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration.
STAT
AstraZeneca set to strike drug pricing deal with Trump (opens STAT)
Published Oct 9, 2025
STAT's feed description
More details of the agreement between Trump and U.K.-based AstraZeneca are set to be shared at the White House this evening.
Delaware Public Media
AstraZeneca makes deal with White House to lower drug prices (opens Delaware Public Media)
Published Oct 9, 2025
Delaware Public Media's feed description
The U.K.-based drugmaker became the second to strike a deal with the Trump administration as part of the president's push to rein in U.S. drug prices.
Insider
TrumpRx makes more drug pricing moves and strikes a deal with AstraZeneca (opens Insider)
Published Oct 9, 2025
Insider's feed description
Trump's pharmaceutical venture strikes a deal with AstraZeneca.
Newsweek
Trump's pharmaceutical deal with AstraZeneca: How drug costs could change (opens Newsweek)
Published Oct 9, 2025
Newsweek's feed description
Trump is set to announce a deal with AstraZeneca to cut U.S. drug prices using a “most-favored-nation” pricing model.
Foxla
President Trump announces new drug-price deal with AstraZeneca (opens Foxla)
Published Oct 10, 2025
Foxla's feed description
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration. Here’s what we know.
West Hawaii Today
Trump, AstraZeneca announce US drug pricing deal at White House (opens West Hawaii Today)
Published Oct 10, 2025
West Hawaii Today's feed description
Trump, AstraZeneca announce US drug pricing deal at White House – Nation and World News | West Hawaii Today
The Guardian
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs (opens The Guardian)
Published Oct 10, 2025
The Guardian's feed description
Company will sell some medicines at a discount to government’s Medicaid health plan in exchange for tariff relief
Al Jazeera
Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca (opens Al Jazeera)
Published Oct 10, 2025
Al Jazeera's feed description
The US president told reporters he didn’t think the deal would have been possible without his 100-percent tariff threat.
PJ Media
Trump’s Leverage Pays Off: AstraZeneca Signs Historic Price Deal (opens PJ Media)
Published Oct 10, 2025
PJ Media's feed description
Trump achieves historic drug price deal with AstraZeneca, marking a significant victory for U.S. healthcare.
CBS News
Trump unveils deal for AstraZeneca to cut Medicaid drug prices and join (opens CBS News)
Published Oct 10, 2025
CBS News's feed description
Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some drugs, President Trump announced Friday, the second major drug company to strike a deal with the administration.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.